A Targeted Mass Spectrometry Approach to Identify Peripheral Changes in Metabolic Pathways of Patients with Alzheimer’s Disease
Authors:
- Pierluigi RevegliaPRPierluigi Reveglia
- Carmela PaolilloCPCarmela Paolillo
- Antonella AngiolilloAntonella Angiolillo
- Gabriella FerrettiGFGabriella Ferretti
- Ruggero AngelicoRARuggero Angelico
- Rossana SirabellaRSRossana Sirabella
- Gaetano CorsoGCGaetano Corso
- Carmela MatroneCMCarmela Matrone
- Alfonso Di CostanzoACAlfonso Di Costanzo
Open Access
- 4 June 2023
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (11) , 9736
Abstract
Alzheimer’s disease (AD), a neurodegenerative disorder, is the most common cause of dementia in the elderly population. Since its original description, there has been intense debate regarding the factors that trigger its pathology. It is becoming apparent that AD is more than a brain disease and harms the whole-body metabolism. We analyzed 630 polar and apolar metabolites in the blood of 20 patients with AD and 20 healthy individuals, to determine whether the composition of plasma metabolites could offer additional indicators to evaluate any alterations in the metabolic pathways related to the illness. Multivariate statistical analysis showed that there were at least 25 significantly dysregulated metabolites in patients with AD compared with the controls. Two membrane lipid components, glycerophospholipids and ceramide, were upregulated, whereas glutamic acid, other phospholipids, and sphingolipids were downregulated. The data were analyzed using metabolite set enrichment analysis and pathway analysis using the KEGG library. The results showed that at least five pathways involved in the metabolism of polar compounds were dysregulated in patients with AD. Conversely, the lipid pathways did not show significant alterations. These results support the possibility of using metabolome analysis to understand alterations in the metabolic pathways related to AD pathophysiology.Keywords
Funding Information
- Italian Ministry of Education, University and Research (2017T9JNLT)
This publication has 59 references indexed in Scilit:
- A new molecular explanation for age‐related neurodegeneration: The Tyr682 residue of amyloid precursor proteinBioEssays, 2013
- Effect of Different Phospholipids on α-Secretase Activity in the Non-Amyloidogenic Pathway of Alzheimer’s DiseaseInternational Journal of Molecular Sciences, 2013
- Lipid Rafts and Alzheimer’s Disease: Protein-Lipid Interactions and Perturbation of SignalingFrontiers in Physiology, 2012
- Activation of Extrasynaptic, But Not Synaptic, NMDA Receptors Modifies Amyloid Precursor Protein Expression Pattern and Increases Amyloid-β ProductionJournal of Neuroscience, 2010
- Regulation of NMDA receptor subunit expression and its implications for LTD, LTP, and metaplasticityNeuropharmacology, 2008
- Glutamate and Neurotrophic Factors in Neuronal Plasticity and DiseaseAnnals of the New York Academy of Sciences, 2008
- Amyloid beta as a regulator of lipid homeostasisTrends in Molecular Medicine, 2007
- Mechanisms of Disease: new therapeutic strategies for Alzheimer's disease—targeting APP processing in lipid raftsNature Clinical Practice Neurology, 2007
- The involvement of lipid rafts in Alzheimer's disease (Review)Molecular Membrane Biology, 2006
- Amyloidogenic processing of the Alzheimer β-amyloid precursor protein depends on lipid raftsJournal of Cell Biology, 2003